This interactive pulmonary hypertension associated with interstitial lung disease (PH-ILD) resource is designed to support awareness, screening, and management considerations for patients with PH-ILD. Through a series of interactive tools, learners can explore a structured screening pathway using the Screen-Detect-Confirm framework, review key findings from the PHINDER study and emerging evidence, and build a personalized PH-ILD care plan based on high-level management considerations. Together, these components provide a practical, evidence-informed resource to help clinicians recognize patterns of concern, understand evolving screening strategies, and navigate important considerations in the care of patients with PH-ILD.
Faculty:
Mohammed Megri, MD, FCCP
Pulmonary and Critical Care Physician
Cleveland Clinic Abu Dhabi
Oksana A. Shlobin, MD, FCCP
Medical Director, Pulmonary Hypertension Program
Director of Education, Advanced Lung Disease Program
Inova Fairfax Hospital
Falls Church, VA
Tejaswini Kulkarni, MD, MPH, FCCP
Associate Professor, Pulmonary, Allergy, and Critical Care Medicine
Director, Interstitial Lung Disease Program
Associate Medical Director, Lung Health Center
The University of Alabama at Birmingham
Birmingham, AL